GGrantIndex
Sort

16,179 grants matching malaria

PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE

$1,014,009
Thomas Meek · Texas A&M Agrilife Research · R01 · FY2019 · AI

International Research in Cambodia: Tropical Medicine and Vector Research

$1,013,982
Jessica Manning · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Red Cell Biology

$1,013,185
David M. Bodine · National Human Genome Research Institute · ZIA · FY2020 · HG

Malaria Parasite Ligands And Host Cell Receptors

$1,012,433
Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.

$1,012,212
B. Kim Lee Sim · Sanaria, Inc. · U01 · FY2025 · AI

Red Cell Biology

$1,011,971
David M. Bodine · National Human Genome Research Institute · ZIA · FY2021 · HG

HVTN 405/HPTN 1901 Characterizing SARS-CoV-2-specific immunity in convalescent individuals

$1,011,819
Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2022 · AI

Epidemiology and Natural History of Cancer-Associated Viruses

$1,010,365
Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern

$1,007,764
Myron S Cohen · Family Health International · UM1 · FY2023 · AI

PFI:BIC - Pathtracker: A smartphone-based system for mobile infectious disease detection and epidemiology

$1,005,692
Brian Cunningham · University Of Illinois At Urbana-Champaign · · FY2015 · TIP

PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE

$1,003,662
Thomas Meek · Texas A&M Agrilife Research · R01 · FY2021 · AI

MIT Laser Biomedical Research Center (P41-RR02594)

$1,001,793
Peter T. So · Massachusetts Institute Of Technology · P41 · FY2015 · EB

Vanderbilt Vaccine and Treatment Evaluation Unit

$1,001,368
Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2025 · AI

Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.

$1,000,000
Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2021 · AI

Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib

$1,000,000
Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · AI

A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products

$1,000,000
Peter F. Billingsley · Sanaria, Inc. · R44 · FY2022 · AI

STRENGTHENING NATIONAL CAPACITY IN MALARIA AND OTHER INFECTIOUS DISEASE OPERATION

$1,000,000
Don P Mathanga · University Of Malawi · U01 · FY2010 · CK

A Unique Automated Bioreactor for Rearing Aseptic Mosquitoes from Larvae to Adults to Support Manufacture of Sanaria PfSPZ Products

$1,000,000
Peter F. Billingsley · Sanaria, Inc. · R44 · FY2023 · AI

Plasmodium vivax recombinant CS protein vaccine for malaria

$1,000,000
B. Kim Lee Sim · Protein Potential, Llc · R44 · FY2011 · AI

IMPROVING MANUFACTURING AND POTENCY OF CRYOPRESERVED MALARIA SPOROZOITE VACCINE

$1,000,000
Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2013 · AI

CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM

$1,000,000
Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2008 · RR

Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib

$1,000,000
Richard W Scott · Polymedix, Inc, · R44 · FY2012 · AI

A glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with a live attenuated sporozoite malaria vaccine

$1,000,000
Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2018 · AI

Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria

$1,000,000
Vinayak S Joshi · Visionquest Biomedical Inc · R44 · FY2021 · AI

Universal Attenuated Sporozoite Vaccine and Challenge System

$1,000,000
Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2013 · AI